B-cell receptor recognizing H5 hemagglutinin epitopes (H5-BCR)

B-cell receptors (BCRs) recognizing H5 hemagglutinin (HA) epitopes are specialized membrane-bound immunoglobulins on B lymphocytes that specifically interact with the HA protein of H5-subtype influenza A viruses, such as H5N1. These receptors are central to the adaptive immune response, as their engagement by viral antigens or vaccines initiates the signaling cascade required for the production of protective antibodies (Science, 2019). In therapeutic contexts, these BCRs are the primary targets of H5N1 vaccines, which aim to stimulate the expansion of B-cell clones capable of neutralizing the virus by blocking its attachment to host sialic acid receptors. Research focuses on identifying BCRs that target the highly conserved HA stem region to achieve broad protection across different H5 clades and potentially other influenza subtypes (Nature, 2021). The specificity and affinity of these BCRs determine the effectiveness of the humoral immune response against pandemic-potential avian influenza. Monitoring the activation and maturation of these BCR-bearing cells is crucial for evaluating vaccine efficacy and developing next-generation universal influenza immunotherapies.

Other names

H5-specific B-cell receptorH5 HA-reactive BCRHemagglutinin H5-specific B-cell receptorH5-neutralizing B-cell receptorH5N1-specific B-cell receptor

Vaccine-delivered H5 hemagglutinin antigens bind to and cross-link specific B-cell receptors, triggering intracellular signaling via the Ig-alpha/Ig-beta (CD79A/CD79B) complex, which leads to B-cell proliferation, affinity maturation, and differentiation into plasma cells that secrete H5-neutralizing antibodies (FDA, 2020; Nature Reviews Immunology, 2023).